Dr. Haynes has been invited to the University of Oregon to present a talk entitled “Drugging the cancer epigenome with synthetic chromatin-based proteins” for the Engineering Biomolecules Mini-Symposium on Friday, June 22, 2018 in the Willamette Hall. The mini-symposium is organized by students in the University of Oregon’s Molecular Biology and Biophysics training program, and showcases six world-class researchers from the field of biomolecular engineering.
Dr. Haynes has been invited to the 6th Annual NCI CSSI Science Day Workshop, hosted by the NIH Center for Strategic Scientific Initiatives (CSSI), National Cancer Institute (NCI) in Bethesda, MD. The NCI CSSI has hosted Science Day meetings to convene extramural investigators and NIH/NCI program staff with the goal of facilitating scientific conversations and identifying needs and opportunities across cancer research. Dr. Haynes will present a talk entitled “Engineered chromatin to support epigenetic research and drug development for cancer” on Thursday, June 7, 2018 at the Porter Neuroscience Research Center.
Dr. Haynes has been invited to the University of California Los Angeles (UCLA) to present a talk entitled “A pipeline to engineer synthetic epigenetic proteins derived from chromatin” for the UCLA Bioengineering Department Seminar Series on Thursday, May 17, 2018 in the Engineering V building.
Synthetic Biology: Engineering, Evolution & Design (SEED) is an annual conference that has been hosted in different cities since 2014: Manhattan Beach, CA; Boston, MA; Chicago, IL; and Vancouver, Canada. This year the rapidly growing, highly-visible meeting will take place in Scottsdale, AZ! SEED 2018 will focus on advances in science, technology, applications, and related investments in the field of synthetic biology. This year’s theme will be “synthetic biology at the leading edge of massive DNA synthesis, editing, and decoding.”
The Meeting Chairs are Karmella Haynes (ASU) and Ryan Gill (UC Boulder).
Keynote speakers will include Jim Collins (MIT), Jay Keasling (UC Berkeley), Floyd Romesberg (Scripps), and Pam Ronald (UC Davis).
The call for poster abstracts is open until May 26, 2018.
If you are interested in supporting the conference, please visit the webpage, SEED: Become a Sponsor or Exhibitor, for more information.
Dr. Haynes has been invited to the University of California Irvine to present a talk entitled “In Vitro Development of Chromatin-based Biologics for Breast Cancer” for the UCI Biomedical Engineering Lecture Series on Friday, October 20, 2017 in the McDonnell Douglas Engineering Auditorium (MDEA).
Dr. Haynes has been invited by scientists at the Center for Research and Interdisciplinarity (CRI) to speak at “Charting Future Paths of Open Synthetic Biology” in Paris, France. She will present a talk entitled “Engineering the human genome as chromatin” and participate in advising a strategy (white paper) for the recruitment and support of research fellows in synthetic biology. The invitation to this important international event was given in recognition of Dr. Haynes’ participation at the leading edge of synthetic biology and her high-impact contributions to the field.
ASU Full Circle recently highlighted the emerging Molecular, Tissue, and Cellular Bioengineering (MCTB) community at ASU and the second annual MCTB Symposium, co-chaired by Karmella Haynes.
J. Kullman, 07.27.17, ASU Full Circle: There are more technically precise descriptions of what’s at the core of a growing trend broadening the horizons of biomedical engineering than “the soft, squishy side of bioengineering.” But Karmella Haynes and Kaushal Rege still like the way that sums up what they and about 20 other Arizona State University faculty members are increasingly focusing on in their research and teaching.”
Read more at ASU Full Circle.